These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28933585)

  • 21. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability.
    Kang MR; Kim MS; Oh JE; Kim YR; Song SY; Kim SS; Ahn CH; Yoo NJ; Lee SH
    J Pathol; 2009 Apr; 217(5):702-6. PubMed ID: 19197948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
    Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH
    BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium.
    Keller JW; Franklin JL; Graves-Deal R; Friedman DB; Whitwell CW; Coffey RJ
    J Cell Physiol; 2007 Mar; 210(3):740-9. PubMed ID: 17133351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atg5-mediated autophagy controls apoptosis/anoikis via p53/Rb pathway in naked mole-rat fibroblasts.
    Kim J; Chee WY; Yabuta N; Kajiwara K; Nada S; Okada M
    Biochem Biophys Res Commun; 2020 Jul; 528(1):146-153. PubMed ID: 32451084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Eder S; Arndt A; Lamkowski A; Daskalaki W; Rump A; Priller M; Genze F; Wardelmann E; Port M; Steinestel K
    Cancer Lett; 2017 Jan; 385():160-167. PubMed ID: 27793696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Characterization of Ubiquitin-Like Core Autophagy Protein ATG12 in
    Fischer S; Rijal R; Frommolt P; Wagle P; Konertz R; Faix J; Meßling S; Eichinger L
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12.
    Sun WL; Wang L; Luo J; Zhu HW; Cai ZW
    Cancer Sci; 2018 Oct; 109(10):3129-3138. PubMed ID: 30027574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells.
    Yoo BH; Berezkin A; Wang Y; Zagryazhskaya A; Rosen KV
    Int J Cancer; 2012 Jul; 131(2):357-66. PubMed ID: 21834075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis.
    Rubinstein AD; Eisenstein M; Ber Y; Bialik S; Kimchi A
    Mol Cell; 2011 Dec; 44(5):698-709. PubMed ID: 22152474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells.
    Kinoshita T; Shirouzu M; Kamiya A; Hashimoto K; Yokoyama S; Miyajima A
    Oncogene; 1997 Aug; 15(6):619-27. PubMed ID: 9264402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
    Konstantakou EG; Voutsinas GE; Velentzas AD; Basogianni AS; Paronis E; Balafas E; Kostomitsopoulos N; Syrigos KN; Anastasiadou E; Stravopodis DJ
    Mol Cancer; 2015 Jul; 14():135. PubMed ID: 26198749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
    Chen G; Templeton D; Suttle DP; Stacey DW
    Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleotropic role of RNA binding protein CELF2 in autophagy induction.
    New J; Subramaniam D; Ramalingam S; Enders J; Sayed AAA; Ponnurangam S; Standing D; Ramamoorthy P; O'Neil M; Dixon DA; Saha S; Umar S; Gunewardena S; Jensen RA; Thomas SM; Anant S
    Mol Carcinog; 2019 Aug; 58(8):1400-1409. PubMed ID: 31020708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
    McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
    Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornithine decarboxylase functions in both autophagy and apoptosis in response to ultraviolet B radiation injury.
    Liu YL; Hsiao IH; Lin YH; Lin CL; Jan MS; Hung HC; Liu GY
    J Cell Physiol; 2022 Apr; 237(4):2140-2154. PubMed ID: 35019151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis.
    Zhang F; Virshup DM; Cheong JK
    Oncogene; 2018 Jan; 37(3):363-376. PubMed ID: 28945225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.
    Booth L; Roberts JL; Poklepovic A; Kirkwood J; Sander C; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
    Cancer Biol Ther; 2018 Feb; 19(2):132-137. PubMed ID: 29219657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.